BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24033365)

  • 1. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Nielsen BS; Gniadecki R; Woetmann A; Ødum N; Ralfkiaer E
    APMIS; 2013 Nov; 121(11):1020-4. PubMed ID: 24033365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA in mycosis fungoides and skin inflammation.
    Persson JL
    APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
    Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
    Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene.
    Curcó N; Servitje O; Llucià M; Bertran J; Limón A; Carmona M; Romagosa V; Peyrí J
    Br J Dermatol; 1997 Nov; 137(5):673-9. PubMed ID: 9415223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between cutaneous form of adult T cell leukemia/lymphoma and cutaneous T cell lymphoma by in situ hybridization using a human T cell leukemia virus-1 DNA probe.
    Arai E; Chow KC; Li CY; Tokunaga M; Katayama I
    Am J Pathol; 1994 Jan; 144(1):15-20. PubMed ID: 8291605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.
    Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
    Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
    PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.
    Wismer JM; McKenzie RC; Sauder DN
    Lymphokine Cytokine Res; 1994 Feb; 13(1):21-7. PubMed ID: 8186321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin--an in situ hybridization study.
    Park CK; Ko YH
    Br J Dermatol; 1996 Mar; 134(3):488-93. PubMed ID: 8731674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.
    Sommer VH; Clemmensen OJ; Nielsen O; Wasik M; Lovato P; Brender C; Eriksen KW; Woetmann A; Kaestel CG; Nissen MH; Ropke C; Skov S; Ødum N
    Leukemia; 2004 Jul; 18(7):1288-95. PubMed ID: 15141228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.